Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HUTCHMED (China) (HCM) EBITDA (2016 - 2021)

Historic EBITDA for HUTCHMED (China) (HCM) over the last 6 years, with Q4 2021 value amounting to -$252.5 million.

  • HUTCHMED (China)'s EBITDA changed N/A to -$252.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $176.2 million, marking a year-over-year change of. This contributed to the annual value of -$43.7 million for FY2024, which is 12682.25% down from last year.
  • Per HUTCHMED (China)'s latest filing, its EBITDA stood at -$252.5 million for Q4 2021.
  • In the past 5 years, HUTCHMED (China)'s EBITDA ranged from a high of $220.6 million in Q1 2021 and a low of -$252.5 million during Q4 2021
  • For the 4-year period, HUTCHMED (China)'s EBITDA averaged around -$5.2 million, with its median value being -$5.1 million (2018).
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 34304.17% in 2019, then surged by 26903.74% in 2020.
  • HUTCHMED (China)'s EBITDA (Quarter) stood at -$161.1 million in 2018, then skyrocketed by 76.14% to -$38.4 million in 2019, then soared by 295.36% to $75.1 million in 2020, then tumbled by 436.23% to -$252.5 million in 2021.
  • Its EBITDA stands at -$252.5 million for Q4 2021, versus $220.6 million for Q1 2021 and $75.1 million for Q2 2020.